1McKinney DM,Skvoretz R,Livingston BD,et al.Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL[J].J Immunol,2004,173(3):1941-1950.
2Kuribayashi H,Wakabayashi A,Shimizu M,et al.Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice[J].Biochem Biophys Res Commun,2004,316(2):356-363.
3Reche PA,Reinherz EL.Sequence variability analysis of human class I and class II MHC molecules:functional and structural correlates of amino acid polymorphisms[J].J Mol Biol,2003,331(3):623-641.
4Dorrell L,Willcox BE,Jones EY,et al.Cytotoxic T lymphocytes recognize structurally diverse,clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53[J].Eur J Immunol,2001,31(6):1747-1756.
5Nacsa J,Stanton J,Kunstman KJ,et al.Emergence of cytotoxic T lymphocyte escape mutants following antiretroviral treatment suspension in rhesus macaques infected with SIVmac251[J].Virology,2003,305(1):210-218.
6Sidney J,Southwood S,Pasquetto V,et al.Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype[J].J Immunol,2003,171(11):5964-5974.
7De Groot AS,Bosma A,Chinai N,et al.From genome to vaccine:in silico predictions,ex vivo verification[J].Vaccine,2001,19(31):4385-4395.
8Singh H,Raghava GP.ProPred1:prediction of promiscuous MHC Class-I binding sites[J].Bioinformatics,2003,19(8):1014.
9Corbet S,Nielsen HV,Vinner L,et al.Optimization and immune recognition of multiple novel conserved HLA-A2,human immunodeficiency virus type 1-specific CTL epitopes[J].J Gen Virol,2003,84(Pt 9):2409-2421.
10Altuvia Y,Sette A,Sidney J,et al.A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets[J].Hum Immunol,1997,58 (1):11.
6Taylor B S, Hammer S M. The challenge of HIV-1 subtype diversity[J]. N Engl J Med, 2008,358(15):1590-1602.
7Chan D C, Fass D, Berger J M, et al. Core structure of gp41 from the HIV envelope glycoprotein[J]. Cell Vol, 1997,89:263- 273.
8Yang Kunyu, LI Shaowei, He Fangping, et al. Expression and purification of soluble HIV-1 envelope glycoprotein gp160 mutant from Saccharomyces cerevisiae[J]. J Bioscie Bioeng, 2009, 108(1):5-10.
9Penn-Nicholson A, Han D P, Cho M W, et al. Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope[J]. Virology, 2008,385(372):442- 456.
10Cumming S A, McPhee D A, Maskill W J, et al. Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies[J]. AIDS, 2006,4:83- 86.
